Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

Summary

Objectives: To investigate the relationship between the administration of intravenous (IV) and oral voriconazole (vori) and the occurrence of false positive (1,3) beta-d- glucan (BG) relative to the standard assessment criteria used to diagnose invasive fungal infection in patients with hematologic malignancies.

Timeline

Start

2009-05

Primary completion

2010-07

Completion

2010-07

Drugs

Indications